Quote - "There's nothing intrinsic about an electric vehicle that makes it harder or more expensive to insure, it mostly comes down to insatiable demand for the vehicles and the supply limitations," Jones says. "That supply issue extends to spare parts too."
It seems that the main problem is the cost of repairs, particularly getting spare parts.
That will change eventually.
- Forums
- ASX - By Stock
- Good News & Bad News
Quote - "There's nothing intrinsic about an electric vehicle...
-
- There are more pages in this discussion • 5,911 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.06 |
Change
0.040(1.32%) |
Mkt cap ! $9.210B |
Open | High | Low | Value | Volume |
$3.04 | $3.12 | $3.02 | $47.88M | 15.58M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 321604 | $3.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.07 | 269930 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 98240 | 3.060 |
13 | 82683 | 3.050 |
13 | 75513 | 3.040 |
10 | 29960 | 3.030 |
20 | 88646 | 3.020 |
Price($) | Vol. | No. |
---|---|---|
3.070 | 400 | 1 |
3.080 | 7280 | 2 |
3.090 | 11600 | 2 |
3.100 | 66993 | 13 |
3.110 | 237299 | 9 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
PLS (ASX) Chart |